Isorhamnetin-3-O-β-D-Glucoside for COVID-19

 Isorhamnetin-3-O-β-D-Glucoside has been reported as potentially beneficial for COVID-19 in the following studies.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed isorhamnetin-3-O-β-D-Glucoside in detail.
Zeng et al., Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation, Journal of Food and Drug Analysis, doi:10.38212/2224-6614.3466